Five-year melanoma results for vaccine plus Keytruda

Ben presents five-year data showing roughly 49% reduction in recurrence risk and durable survival improvements.

Play episode from 01:10:39

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!